Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris.
about
Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acneAntimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgarisThe response of human skin commensal bacteria as a reflection of UV radiation: UV-B decreases porphyrin productionPropionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatmentComparative genomics reveals distinct host-interacting traits of three major human-associated propionibacteriaTreatment effects of lysozyme-shelled microbubbles and ultrasound in inflammatory skin disease.Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogenTreating acne with antibiotic-resistant bacterial colonization.Propionibacterium acnes: infection beyond the skin.Propionibacterium acnes: an update on its role in the pathogenesis of acne.Immunotherapy for acne vulgaris: current status and future directions.Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonizationGenetic and functional characterization of the NanA sialidase from Clostridium chauvoei.Proteomics integrated with Escherichia coli vector-based vaccines and antigen microarrays reveals the immunogenicity of a surface sialidase-like protein of Propionibacterium acnes.Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris.Immunoproteomic Identification of In Vivo-Produced Propionibacterium acnes Proteins in a Rabbit Biofilm Infection ModelPassive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgarisStaphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris.Emerging drugs for acne.Bacterial hydrolysis of host glycoproteins - powerful protein modification and efficient nutrient acquisition.Alterations of the Erythrocyte Membrane during SepsisWhat's new in the physiopathology of acne?Phenotype and antimicrobial activity of Th17 cells induced by Propionibacterium acnes strains associated with healthy and acne skin.Recent progress in the research about Propionibacterium acnes strain diversity and acne: pathogen or bystander?Anti-acne drugs in phase 1 and 2 clinical trials.Analysis of the Surface, Secreted, and Intracellular Proteome of Propionibacterium acnes.Inhibitory and anti-inflammatory effects of the Helicobacter pylori-derived antimicrobial peptide HPA3NT3 against Propionibacterium acnes in the skin.Cutibacterium (formerly Propionibacterium) acnes infections associated with implantable devices.Propionibacterium acnes (P. acnes) resistance and antibiotic use in patients attending Australian general practiceStructural and biochemical characterization of the Cutibacterium acnes exo-β-1,4-mannosidase that targets the N-glycan core of host glycoproteins
P2860
Q21089999-3F217714-E28B-49CA-9481-4A4A15AC222FQ24645431-D3FFD4A1-F253-4844-BFA5-F8D533CC6055Q28484643-6972A4D5-F443-46A0-B59F-3330CCF1806FQ28741201-095B5131-4A21-4558-8A2A-95225CD2DBC5Q30009551-D73B6C75-49D4-4680-B34E-44851471BC25Q30365103-9733A9B3-03D5-47EE-B083-FF44D66F63A7Q30407733-A93E191F-43B0-43CF-94D1-45F249D65668Q34167188-F087EBDC-2DFE-49E5-93AE-5D88EEB3EDC5Q34235765-3EE50E68-DDD3-4062-BA44-7AFB45110D01Q34361098-40F425B7-7A20-41E4-B82D-8700D925DEB3Q34369858-8A58733D-5B3D-4569-9E8F-3C5249E2F640Q34398619-5CC08C61-A83F-441D-AE8F-107AA154980BQ34540938-F40DEDC2-30F8-4103-9FF3-AB2760386942Q34759942-9E2B5E1C-5106-4060-9DF5-105C27CB7821Q34759960-11E40D52-D5B2-4940-BDAB-A6469FC3E9B0Q35548040-DABB7DD4-1123-42C4-B4E2-B2FDD987CAEAQ36072897-202756F7-D6A9-4701-9651-84A5674E51A8Q37463929-00AC3F9C-CA8B-4460-8970-EBA6EF321F4FQ37601477-403AB647-0DCF-4AF6-AE65-E4151C97E81AQ37973650-663FFD48-F0E9-4FFD-8A3C-5F73D7F2BCCEQ38016896-950D2F7D-30BC-49DB-84F0-D97E6D7E319AQ38341846-FAE695DF-733A-44EA-8566-37767673D3F1Q38597444-553B2D9E-81B3-4F27-951E-140FE4BBAFD2Q38841503-F580F44C-05FF-4F89-842F-F0CFA5A66711Q39382177-0B936666-639D-44C0-BE9E-7102FF687A7DQ41126889-1DB0D4CB-83E0-4CD8-8F56-D970121900E2Q41702165-44D0326B-6844-4E00-9CB7-8D054979E111Q48325967-0F704064-E2D9-42A2-A705-ED101543EF45Q57651389-A52C513F-FCAF-4B57-B46C-794CCE42BFA3Q58691505-98257A48-DE28-44CC-9C84-DA56455288D2
P2860
Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Vaccination targeting a surfac ...... ew treatment of acne vulgaris.
@ast
Vaccination targeting a surfac ...... ew treatment of acne vulgaris.
@en
Vaccination targeting a surfac ...... ew treatment of acne vulgaris.
@nl
type
label
Vaccination targeting a surfac ...... ew treatment of acne vulgaris.
@ast
Vaccination targeting a surfac ...... ew treatment of acne vulgaris.
@en
Vaccination targeting a surfac ...... ew treatment of acne vulgaris.
@nl
prefLabel
Vaccination targeting a surfac ...... ew treatment of acne vulgaris.
@ast
Vaccination targeting a surfac ...... ew treatment of acne vulgaris.
@en
Vaccination targeting a surfac ...... ew treatment of acne vulgaris.
@nl
P2093
P2860
P1433
P1476
Vaccination targeting a surfac ...... ew treatment of acne vulgaris.
@en
P2093
Cheng-Po Huang
Christos C Zouboulis
Chun-Ming Huang
Richard L Gallo
Teruaki Nakatsuji
Yu-Tsueng Liu
P2860
P356
10.1371/JOURNAL.PONE.0001551
P407
P577
2008-02-06T00:00:00Z